AVADEL PHARMACEUTICALS PLC·4

Mar 4, 6:26 AM ET

MCHUGH THOMAS S 4

4 · AVADEL PHARMACEUTICALS PLC · Filed Mar 4, 2024

Insider Transaction Report

Form 4
Period: 2024-02-20
MCHUGH THOMAS S
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-02-20+157,500157,500 total
    Exercise: $13.57Exp: 2034-02-20ADSs (157,500 underlying)
Footnotes (2)
  • [F1]Options become exercisable as to 39,375 ADSs on each of the first four anniversaries after the 2/20/2024 grant date.
  • [F2]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.

Documents

1 file
  • 4
    tm247077-6_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT